Trefis Team
4 min read
Today’s big story: Will 2027 Be A 2022 Repeat For Stocks?
Buy low, never at the top. Few investing rules are repeated more often. Edwards Lifesciences (EW) stock closed at a 52-week high on November 13, 2026. By November 19 it had slipped to $103.88, about 3% below that high. By that rule, anyone buying now has come too late. Does that rule hold for Edwards?
Why Edwards Stock Is Near A High
Edwards stock is near a high because investors now pay more for each dollar of its net profit. That is so even though net profit fell. The shares rose 23.6% over the past year. Yet net income fell 25.2% over the four quarters ended September 2026, against the four quarters before. Operating income rose to $1.92 billion from $1.62 billion over the same periods. For the third quarter alone, management said GAAP earnings of $0.53 a share were held down mainly by a write-down of a research and development asset.
This shows up in the price-to-earnings multiple, which measures what investors pay for each dollar of profit. The multiple now stands at 58.6, up from 35.4 a year ago. So the rise in the share price came from the higher multiple, not from higher profit.
At 58.6 times its profit, Edwards stock costs far more than it did a year ago, at 35.4 times. If that price has you holding off on buying, your cash does not have to sit idle in the meantime. The Trefis Income Solution pays a dividend yield about 3 times the S&P 500’s, from 50 companies that have paid dividends for at least 10 years in a row. See what it pays.
Behind that higher share price is a business with steadily growing sales. Revenue rose 13.4% over the same four quarters. The fastest-growing of its three businesses is Transcatheter Mitral and Tricuspid Therapies, sold under names such as PASCAL, EVOQUE and SAPIEN M3. Management said this business’s third-quarter sales rose 45.6% from a year earlier.
What Happened After Edwards Stock’s Earlier Highs?
The better question is not whether Edwards stock is currently too high, but what happened to investors who bought it at its earlier highs. Between November 2016 and November 2025, Edwards set nine such highs. Take a guess: after how many was the stock higher a year later?
The answer is seven of the nine. Here is a look at each high and what followed: